These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 62181)

  • 41. Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
    Sciarra F; Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Concolino G
    Horm Res; 1977; 8(3):129-38. PubMed ID: 903075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ergoline congeners as potential inhibitors of prolactin release. 2.
    Rusterholz DB; Barfknecht CF; Clemens JA
    J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of 2-bromo-alpha-ergocryptine (CB 154) on plasma prolactin, LH and testosterone levels, accessory reproductive glands and spermatogenesis in lambs during puberty.
    Ravault JP; Courot M; Garnier D; Pelletier J; Terqui M
    Biol Reprod; 1977 Sep; 17(2):192-7. PubMed ID: 578119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of body fat stores by inhibition of prolactin secretion.
    Cincotta AH; Meier AH
    Experientia; 1987 Apr; 43(4):416-7. PubMed ID: 3569491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperprolactinaemia and luteal insufficiency.
    Seppälä M; Ranta T; Hirvonen E
    Lancet; 1976 Jan; 1(7953):229-30. PubMed ID: 55535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of prolactin by ergoline congeners.
    Barfknecht CF; Rusterholz DB
    J Med Chem; 1974 Mar; 17(3):308-12. PubMed ID: 4811226
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bromocriptine (Parlodel). A prolactin inhibiting dopamine receptor agonist].
    Andersen AN
    Ugeskr Laeger; 1977 May; 139(22):1311-3. PubMed ID: 577320
    [No Abstract]   [Full Text] [Related]  

  • 52. Control of plasma aldosterone concentration during hemodialysis.
    Read VH; McCaa CS; Bower JD; McCaa RE
    Proc Clin Dial Transplant Forum; 1972; 2():93-9. PubMed ID: 4619676
    [No Abstract]   [Full Text] [Related]  

  • 53. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
    Krysiak R; Okopien B
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bromocriptine treatment of secondary amenorrhoea.
    Seppalå M; Hirvonen E; Ranta T
    Lancet; 1976 May; 1(7970):1154-6. PubMed ID: 58200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine agonist treatment before and after the birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian hamsters, Phodopus campbelli.
    Brooks PL; Vella ET; Wynne-Edwards KE
    Horm Behav; 2005 Mar; 47(3):358-66. PubMed ID: 15708766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
    Pisarek H; Stepien H
    Histol Histopathol; 1992 Jan; 7(1):111-7. PubMed ID: 1576426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aldosterone response to angiotensin II in patients with terminal renal failure and after bilateral nephrectomy.
    Woods TJ; McCaa RE; Bower JD; McCaa CS
    Trans Am Soc Artif Intern Organs; 1974; 20A():154-60. PubMed ID: 4375328
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulation of aldosterone in anephric man maintained with regular haemodialysis.
    Weidmann P; Horton R; Franklin SS; Fichman M; Gral T; Maxwell MH
    Proc Eur Dial Transplant Assoc; 1972; 9():74-83. PubMed ID: 4359254
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of lactation in rabbits by 2-Br-alpha-Ergokryptine-mesilate (CB154).
    Flückiger E; Billeter E; Wagner HR
    Arzneimittelforschung; 1976; 26(1):51-3. PubMed ID: 947176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.